Michael L Dougan

24PUBLICATIONS
203CO-AUTHORS
Haematological tumoursBiologically active moleculesElectrical energy generation (incl. renewables, excl. photovoltaics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|May 25, 2026
Activation-dependent lentiviruses enable antigen-specific T cell expansion and transduction.

|Feb 19, 2026
Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics.

Grayson E Rodriguez, Yang Zhao, Yoko Nishiga

|Jan 27, 2026
Ruxolitinib for ciltacabtagene autoleucel-associated refractory diarrhea.

Viktoria Blumenberg, Filippo Birocchi, Angela Shih

|Nov 07, 2025
Peptide-MHC-targeted retroviruses enable in vivo expansion and gene delivery to tumor-specific T cells.

Ellen J K Xu, Blake E Smith, Winiffer D Conce Alberto

|Sep 26, 2025
Design of a potent interleukin-21 mimic for cancer immunotherapy.

Jung-Ho Chun, Birkley S Lim, Suyasha Roy

|Sep 03, 2025
Second Mitochondrial Activator of Caspases Mimetics Accelerate Progression of Locally Advanced Head and Neck Cancer.

Michael Dougan, Stephanie K Dougan

Pageof 4

Frequent Collaborators

6 joint publications

Stephanie K Dougan

5 joint publications

Meghan J Mooradian

4 joint publications

Leyre Zubiri

3 joint publications

Steven M Blum